Miklós Koppán

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

Attila Nagy, Andrew V. Schally, Gábor Halmos et al. · Proceedings of the National Academy of Sciences · 1998 · 144 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

Najib Lamharzi, Andrew V. Schally, Miklós Koppán et al. · Proceedings of the National Academy of Sciences · 1998 · 91 citations

Medicine, Endocrinology, Oncology +16

Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome

Ákos Várnagy, József Bódis, Zoltán Mánfai et al. · Fertility and Sterility · 2009 · 90 citations · Full text

Medicine, Gynecology, Pharmacotherapy +12

Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.

Miklós Koppán, Ahmed Nagy, Andrew V. Schally et al. · PubMed · 1998 · 56 citations · Full text

Medicine, Oncology, Pharmacology +14

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone

Magdolna Kovács, Andrew V. Schally, Attila Nagy et al. · Proceedings of the National Academy of Sciences · 1997 · 55 citations

Medicine, Endocrinology, Pharmacology +17